Gonzalez et al. [42] reported increased risks due to failed PDA closure, PDA recurrence, and increased levels of a prostaglandin (6-ketoprostaglandin F1α [6-keto PGF1α]) and tumor necrosis factor alpha in infants with postnatal infections. The gene discussed is TNF; the disease is Patent ductus arteriosus.